Company Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Reports 2Q:15 Results

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing proprietary therapies for prostate cancer and other hormonally driven diseases, today reported …

Thursday Insights: MannKind Corporation (MNKD), Plasmatech Biopharmaceuticals Inc (PTBI), Tokai Pharmaceuticals Inc (TKAI), Box Inc (BOX)

MannKind Corporation (NASDAQ:MNKD) shares are tumbling 6.87% in mid-day trading to $5.

Tokai Pharmaceuticals Inc: The Small Cap Biotech With The Billion Dollar Prostate Cancer Drug

  Those that follow my biotech recommendations know that I look for undervalued small cap stocks with significant upside. Some may be momentum …

William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015

2014 has been an eventful year on Wall Street. Now that the year is coming to an end, what stocks should investors be …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts